Brumm Joshua T
Insider CIK 1528826 · CBIO Chief Executive Officer, Director · ZLTQ VP of Corporate Development · VSAR Chief Financial Officer · KLDO See Remarks · DYN See Remarks, Director · PCYC EVP, Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CBIO CRESCENT BIOPHARMA, INC. | S Sale | 2026-09-18 | 2026-09-18 | 7,837 | $16.71 | $131.0K | 271,765 | SEC↗ |
| CBIO CRESCENT BIOPHARMA, INC. | S Sale | 2026-09-18 | 2026-09-18 | 7,837 | $16.71 | $131.0K | 271,765 | SEC↗ |
| CBIO CRESCENT BIOPHARMA, INC. | S Sale | 2026-09-16 | 2026-09-18 | 1,610 | $17.90 | $28.8K | 279,602 | SEC↗ |
| CBIO CRESCENT BIOPHARMA, INC. | S Sale | 2026-09-16 | 2026-09-18 | 1,610 | $17.90 | $28.8K | 279,602 | SEC↗ |
| CBIO CRESCENT BIOPHARMA, INC. | S Sale | 2026-06-22 | 2026-06-23 | 42,305 | $17.99 | $761.1K | 281,212 | SEC↗ |
| CBIO CRESCENT BIOPHARMA, INC. | A Award deriv | 2025-12-15 | 2025-12-17 | 180,467 | — | $0 | 180,467 | SEC↗ |
| CBIO CRESCENT BIOPHARMA, INC. | A Award | 2025-12-15 | 2025-12-17 | 10,000 | — | $0 | 323,517 | SEC↗ |
| CBIO CRESCENT BIOPHARMA, INC. | A Award | 2025-12-15 | 2025-12-17 | 45,117 | — | $0 | 313,517 | SEC↗ |
| CBIO CRESCENT BIOPHARMA, INC. | A Award deriv | 2025-12-08 | 2025-12-10 | 345,672 | — | $0 | 345,672 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2024-03-11 | 2024-03-12 | 50,000 | — | $0 | 83,269 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-12 | 7,769 | $26.12 | $202.9K | 546,616 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-12 | 9,928 | $26.10 | $259.1K | 554,385 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-12 | 40,072 | $25.42 | $1.02M | 564,313 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2024-03-11 | 2024-03-12 | 50,000 | $5.54 | $277.0K | 604,385 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-12 | 8,618 | $25.93 | $223.5K | 537,998 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2024-03-08 | 2024-03-12 | 209,412 | — | $0 | 133,269 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2024-03-08 | 2024-03-12 | 153,931 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-08 | 2024-03-12 | 435 | $27.38 | $11.9K | 554,385 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-08 | 2024-03-12 | 160,670 | $26.72 | $4.29M | 554,820 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-08 | 2024-03-12 | 202,238 | $25.30 | $5.12M | 715,490 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2024-03-08 | 2024-03-12 | 209,412 | $5.54 | $1.16M | 917,728 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2024-03-08 | 2024-03-12 | 153,931 | $5.54 | $852.8K | 708,316 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-07 | 2024-03-11 | 9,086 | $25.85 | $234.9K | 554,385 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2024-03-01 | 2024-03-01 | 57,843 | — | $0 | 44,500 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2024-03-01 | 2024-03-01 | 36,637 | — | $0 | 342,681 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-01 | 2024-03-01 | 1,414 | $29.70 | $42.0K | 563,471 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-01 | 2024-03-01 | 18,976 | $28.25 | $536.1K | 638,975 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2024-03-01 | 2024-03-01 | 94,480 | $5.54 | $523.4K | 657,951 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-03-01 | 2024-03-01 | 74,090 | $29.23 | $2.17M | 564,885 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2024-02-29 | 2024-03-01 | 5,520 | — | $0 | 102,343 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2024-02-29 | 2024-03-01 | 5,520 | $5.54 | $30.6K | 568,991 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-29 | 2024-03-01 | 5,520 | $27.50 | $151.8K | 563,471 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | G Gift | 2024-01-29 | 2024-01-31 | 1,500 | — | $0 | 563,471 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | G Gift | 2024-01-29 | 2024-01-31 | 20,000 | — | $0 | 564,971 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2024-01-04 | 2024-01-04 | 200,000 | — | $0 | 107,863 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2024-01-04 | 2024-01-04 | 18,536 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-01-04 | 2024-01-04 | 180,235 | $18.40 | $3.32M | 623,272 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2024-01-04 | 2024-01-04 | 200,000 | $5.54 | $1.11M | 803,507 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2024-01-04 | 2024-01-04 | 18,536 | $1.03 | $19.1K | 603,507 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-01-04 | 2024-01-04 | 38,301 | $19.05 | $729.6K | 584,971 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2024-01-03 | 2024-01-04 | 51,183 | — | $0 | 18,536 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-01-03 | 2024-01-04 | 16,026 | $20.50 | $328.5K | 584,971 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-01-03 | 2024-01-04 | 19,775 | $19.03 | $376.3K | 600,997 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-01-03 | 2024-01-04 | 15,382 | $18.34 | $282.1K | 620,772 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2024-01-03 | 2024-01-04 | 51,183 | $1.03 | $52.7K | 636,154 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2023-12-11 | 2023-12-12 | 7,585 | $10.72 | $81.3K | 584,971 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2023-11-15 | 2023-11-16 | 139,750 | — | $0 | 139,750 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award | 2023-11-15 | 2023-11-16 | 358,877 | — | $0 | 592,556 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2023-09-18 | 2023-09-20 | 12,032 | $9.41 | $113.2K | 233,679 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2023-09-12 | 2023-09-13 | 7,672 | $10.41 | $79.9K | 245,711 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2023-06-12 | 2023-06-12 | 171,360 | — | $0 | 69,719 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2023-06-12 | 2023-06-12 | 171,360 | $1.03 | $176.5K | 441,131 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2023-06-12 | 2023-06-12 | 187,748 | $12.61 | $2.37M | 253,383 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2023-06-09 | 2023-06-12 | 76,582 | — | $0 | 241,079 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2023-06-09 | 2023-06-12 | 76,582 | $13.34 | $1.02M | 269,771 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2023-06-09 | 2023-06-12 | 76,582 | $1.03 | $78.9K | 346,353 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2023-06-08 | 2023-06-12 | 30,088 | — | $0 | 317,661 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2023-06-08 | 2023-06-12 | 14,189 | $13.47 | $191.1K | 269,771 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | G Gift | 2023-06-08 | 2023-06-12 | 20,000 | — | $0 | 302,483 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2023-06-08 | 2023-06-12 | 46,811 | $13.15 | $615.6K | 283,960 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2023-06-08 | 2023-06-12 | 30,088 | $1.03 | $31.0K | 330,771 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | G Gift | 2023-06-08 | 2023-06-12 | 1,800 | — | $0 | 300,683 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2023-03-14 | 2023-03-15 | 7,318 | $13.33 | $97.5K | 322,483 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2022-12-12 | 2022-12-13 | 3,322 | $10.87 | $36.1K | 329,801 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2022-12-09 | 2022-12-13 | 222,000 | — | $0 | 222,000 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award | 2022-12-09 | 2022-12-13 | 144,000 | — | $0 | 333,123 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2022-10-10 | 2022-10-11 | 195,800 | — | $0 | 347,749 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2022-10-10 | 2022-10-11 | 195,800 | $1.03 | $201.7K | 400,423 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2022-10-10 | 2022-10-11 | 195,800 | $12.46 | $2.44M | 204,623 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | G Gift | 2022-10-10 | 2022-10-11 | 13,000 | — | $0 | 191,623 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | G Gift | 2022-10-10 | 2022-10-11 | 2,500 | — | $0 | 189,123 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise deriv | 2022-10-07 | 2022-10-11 | 14,200 | — | $0 | 543,549 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | M Exercise | 2022-10-07 | 2022-10-11 | 14,200 | $1.03 | $14.6K | 218,823 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2022-10-07 | 2022-10-11 | 14,200 | $13.37 | $189.9K | 204,623 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | D To issuer | 2022-09-20 | 2022-09-21 | 11,836 | $13.70 | $162.2K | 204,623 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | D To issuer | 2022-09-15 | 2022-09-15 | 3,480 | $14.05 | $48.9K | 216,459 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | D To issuer | 2022-07-06 | 2022-07-06 | 10,963 | $8.24 | $90.3K | 219,939 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2022-07-05 | 2022-07-06 | 78,386 | — | $0 | 78,386 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2022-07-05 | 2022-07-06 | 153,931 | — | $0 | 153,931 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award | 2022-07-05 | 2022-07-06 | 24,118 | — | $0 | 230,902 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | D To issuer | 2022-06-14 | 2022-06-15 | 3,540 | $4.95 | $17.5K | 206,784 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2022-03-11 | 2022-03-14 | 3,384 | $8.73 | $29.5K | 210,324 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2021-12-10 | 2021-12-14 | 177,285 | — | $0 | 177,285 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award | 2021-12-10 | 2021-12-14 | 118,190 | — | $0 | 213,708 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | G Gift | 2021-10-01 | 2021-10-04 | 3,500 | — | $0 | 95,518 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2021-09-21 | 2021-09-22 | 4,584 | $16.11 | $73.8K | 99,018 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-22 | 3,425 | $15.61 | $53.5K | 103,602 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award | 2020-09-17 | 2020-09-18 | 107,027 | — | $0 | 107,027 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | A Award deriv | 2020-09-16 | 2020-09-18 | 320,781 | — | $0 | 320,781 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | A Award deriv | 2019-03-04 | 2019-03-04 | 80,000 | — | $0 | 80,000 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-10-19 | 2017-10-23 | 1,326 | $2.55 | $3.4K | 201,269 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-10-06 | 2017-10-10 | 97,000 | — | $0 | 202,595 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-06-13 | 2017-06-14 | 1,421 | $16.05 | $22.8K | 105,595 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-05-16 | 2017-05-17 | 1,263 | $17.40 | $22.0K | 107,016 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise deriv | 2017-02-24 | 2017-02-28 | 30,000 | — | $0 | 122,108 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-02-24 | 2017-02-28 | 5,653 | $22.05 | $124.6K | 105,779 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-02-24 | 2017-02-28 | 6,008 | $21.46 | $128.9K | 111,432 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-02-24 | 2017-02-28 | 18,339 | $20.42 | $374.5K | 117,440 | SEC↗ |
| VSAR Versartis, Inc. | M Exercise | 2017-02-24 | 2017-02-28 | 30,000 | $2.53 | $75.9K | 135,779 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2017-01-30 | 2017-01-31 | 2,945 | $13.85 | $40.8K | 105,779 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2017-01-27 | 2017-01-31 | 65,590 | — | $0 | 65,590 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-01-27 | 2017-01-31 | 43,900 | — | $0 | 108,724 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2016-12-27 | 2016-12-29 | 990 | $15.85 | $15.7K | 64,824 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2016-12-07 | 2016-12-08 | 3,021 | $13.25 | $40.0K | 65,814 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2016-10-11 | 2016-10-13 | 10,000 | — | $0 | 68,835 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2016-06-15 | 2016-06-17 | 1,448 | $10.63 | $15.4K | 58,835 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2016-05-20 | 2016-05-20 | 1,265 | $7.87 | $10.0K | 60,283 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2016-01-28 | 2016-02-01 | 83,800 | — | $0 | 83,800 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2016-01-28 | 2016-02-01 | 26,000 | — | $0 | 61,548 | SEC↗ |
| VSAR Versartis, Inc. | S Sale | 2015-12-30 | 2016-01-04 | 990 | $12.44 | $12.3K | 35,548 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2015-11-12 | 2015-11-13 | 2,500 | $9.99 | $25.0K | 36,538 | SEC↗ |
| VSAR Versartis, Inc. | F Tax w/h | 2015-06-11 | 2015-06-15 | 1,375 | $17.28 | $23.8K | 34,038 | SEC↗ |
| VSAR Versartis, Inc. | F Tax w/h | 2015-06-11 | 2015-06-15 | 1,222 | $19.90 | $24.3K | 35,413 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2014-12-26 | 2014-12-30 | 24,373 | — | $0 | 24,373 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2014-12-26 | 2014-12-30 | 10,445 | — | $0 | 36,635 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2014-06-11 | 2014-06-13 | 32,000 | — | $0 | 32,000 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2014-06-11 | 2014-06-13 | 15,000 | — | $0 | 25,000 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2014-04-15 | 2014-04-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PCYC PHARMACYCLICS INC | A Award deriv | 2012-10-26 | 2012-10-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PCYC PHARMACYCLICS INC | A Award deriv | 2012-08-09 | 2012-08-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | A Award deriv | 2012-02-17 | 2012-04-30 | 26,316 | — | $0 | 26,316 | SEC↗ |
| ZLTQ Zeltiq Aesthetics Inc | A Award | 2012-02-17 | 2012-04-30 | 7,692 | — | $0 | 7,692 | SEC↗ |